https://ift.tt/2IVHF6y

The stock moved higher by 6.4% to Rs 458 on BSE after the company announced that its JV has received USFDA nod for tapeworm infection treatment drug.

from Markets https://ift.tt/2C2rfEf

Comments

Popular posts from this blog

CAG flags tax irregularities by banks, NBFCs

IIT PhDs in demand for high-end R&D jobs